Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Small cell lung cancer associated with systemic sclerosis.

Nobuhiro Kanaji¹, Jiro Fujita, Shuji Bandoh

¹First Department of Internal Medicine, faculty of Medicine, Kagawa University, Kagawa.

Internal Medicine (Tokyo, Japan)

|May 18, 2005

Summary

This study suggests a link between small cell lung cancer (SCLC) and interstitial pneumonia in patients with systemic sclerosis (SSc). The findings highlight a potential association, particularly in non-smokers with this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical Implementation Gap of Comprehensive Genomic Profiling in Pancreatic Cancer: A Real-world Study.

In vivo (Athens, Greece)·2026

Same author

Phase II study of ramucirumab plus erlotinib for treatment-naïve patients with EGFR-mutant non-squamous non-small cell lung cancer and pleural effusion (RELAY-Effusion).

Lung cancer (Amsterdam, Netherlands)·2026

Same author

Efficacy and Safety of First-Line Ramucirumab Plus Erlotinib for <i>EGFR</i> L858R-Mutated NSCLC in Real-World Practice: A Retrospective Multicenter REAL-SPEED Analysis.

JTO clinical and research reports·2026

Same author

Histopathological Heterogeneity in Pulmonary Hyalinizing Granulomas: A Case Report.

Respirology case reports·2026

Same author

Ramucirumab and erlotinib combination as first-line treatment for advanced or recurrent non-small cell lung cancer harboring <i>EGFR</i> Exon21 L858R mutation: a multicenter retrospective observational cohort study in Japan (REAL-SPEED).

Therapeutic advances in medical oncology·2025

Same author

Effects of consultations and interventions in a pharmacist-led outpatient clinic on duration of treatment and adverse events with osimertinib.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2025

Area of Science:

Pulmonology
Rheumatology
Oncology

Background:

Systemic sclerosis (SSc) is an autoimmune disease that can affect the lungs.
Small cell lung cancer (SCLC) is a rare but aggressive form of lung cancer.
The association between SSc-related interstitial pneumonia and SCLC is not well-established.

Purpose of the Study:

To investigate the potential association between SCLC and interstitial pneumonia in patients with SSc.
To review existing literature on SCLC in SSc patients.
To analyze clinical characteristics of SCLC in non-smokers with SSc-related interstitial pneumonia.

Main Methods:

Case report of a 51-year-old non-smoking female with SCLC and SSc-related interstitial pneumonia.
Literature review of 16 additional cases of SCLC associated with SSc.

Related Experiment Videos

Analysis of patient demographics, smoking status, and tumor characteristics.

Main Results:

The majority of reviewed SCLC patients with SSc were women.
In non-smoking patients, SCLC occurred in the peripheral lung fields.
A potential association between SCLC and SSc-related interstitial pneumonia was observed.

Conclusions:

SCLC is rare in non-smokers, suggesting a possible link with SSc-related interstitial pneumonia.
Interstitial pneumonia may be a complicating factor in the development of SCLC in SSc patients.
Further research is warranted to elucidate the relationship between SCLC and SSc-related interstitial pneumonia.